Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Lung Neoplasms and BCL2L11[original query] |
---|
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Apr 20 (7): 2001-10. Costa Carlota, Molina Miguel Angel, Drozdowskyj Ana, Giménez-Capitán Ana, Bertran-Alamillo Jordi, Karachaliou Niki, Gervais Radj, Massuti Bartomeu, Wei Jia, Moran Teresa, Majem Margarita, Felip Enriqueta, Carcereny Enric, Garcia-Campelo Rosario, Viteri Santiago, Taron Miquel, Ono Mayumi, Giannikopoulos Petros, Bivona Trever, Rosell Rafa |
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer. Oncotarget 2017 Apr . Soh Sheila X, Siddiqui Fahad J, Allen John C, Kim Go Woon, Lee Jae Cheol, Yatabe Yasushi, Soda Manabu, Mano Hiroyuki, Soo Ross A, Chin Tan-Min, Ebi Hiromichi, Yano Seiji, Matsuo Keitaro, Niu Xiaomin, Lu Shun, Isobe Kazutoshi, Lee Jih-Hsiang, Yang James C, Zhao Mingchuan, Zhou Caicun, Lee June-Koo, Lee Se-Hoon, Lee Ji Yun, Ahn Myung-Ju, Tan Tira J, Tan Daniel S, Tan Eng-Huat, Ong S Tiong, Lim Wan-Te |
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer. Cancer 2017 Mar . Zhang Limin, Jiang Tao, Li Xuefei, Wang Yan, Zhao Chao, Zhao Sha, Xi Lei, Zhang Shijia, Liu Xiaozhen, Jia Yijun, Yang Hui, Shi Jinpeng, Su Chunxia, Ren Shengxiang, Zhou Caic |
Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study. Cancer science 2019 12 111 (2): 679-686. Lei Lei, Wang Wen-Xian, Zhu You-Cai, Li Jin-Luan, Fang Yong, Wang Hong, Zhuang Wu, Zhang Yin-Bin, Wang Li-Ping, Fang Mei-Yu, Xu Chun-Wei, Wang Xiao-Jia, Lv Tang-Feng, Song Yo |
Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients. Oncology letters 2020 4 19 (5): 3495-3505. Ruan Xingya, Sun Yonghua, Wang Wei, Ye Jianwei, Zhang Daoyun, Gong Ziying, Yang Mingx |
Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy. Lung cancer (Amsterdam, Netherlands) 2020 Dec 151 39-43. Li Xuanzong, Zhang Dai, Li Butuo, Zou Bing, Wang Shijiang, Fan Bingjie, Li Wanlong, Yu Jinming, Wang Linl |
Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients. Frontiers in oncology 2022 1 11 806845. Hu Mingming, Tan Jinjing, Liu Zhentian, Li Lifeng, Zhang Hongmei, Zhao Dan, Li Baolan, Gao Xuan, Che Nanying, Zhang Tongm |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: